NCT05927012 2023-11-24
A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
Keros Therapeutics, Inc.
Phase 2 Withdrawn
Keros Therapeutics, Inc.
Pierre Fabre Pharma AG
Vifor Pharma
VIFORFRANCE
FrieslandCampina WAMCO Nigeria PLC
Vifor Pharma
J. Uriach and Company